CMS is considering five applications for new technology add-on payments for FY 2010. In order for technology to qualify for an additional payment beyond the payment for the associated MS-DRG, the applicant must demonstrate that the medical service or technology (1) is new (generally not available on the open market for more than two to three years), (2) is high cost relative to other cases in the relevant MS-DRG(s), and (3) offers substantial clinical improvement over existing services or technologies for the Medicare patient population. The applications for new technology add-on payments include a laser treatment for intracranial tumors, a chemotherapy drug used to treat leukemia, a treatment for myocardial infarctions, an imaging system for coronary arteries and a valve system used for treating lung air leaks.